Kala Bio (KALA) Price to Book (2017 - 2026)
Kala Bio's (KALA) quarterly Price to Book came in at 2.92 in Q2 2026, up 100.59% year-over-year from 1.46 in Q2 2025, and down 69.36% quarter-over-quarter from 9.54 in Q1 2026.
Analysis
Kala Bio (KALA) Price to Book (2017 - 2026) Analysis & Trends
Kala Bio has disclosed Price to Book across 10 years of filings, most recently posting 2.92 for Q2 2026.
- In Q2 2026, Price to Book rose 100.59% year-over-year to 2.92; the TTM figure through Jun 2026 stood at 2.92 (up 100.59% YoY), while the FY2025 annual figure was 32.38, down 69.69% from the prior year.
- Price to Book came in at 2.92 for Q2 2026 at Kala Bio, down from 9.54 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 323.86 in Q1 2025 to a low of 956.1 in Q1 2022.
- Average Price to Book over 5 years is 49.68, with a median of 76.19 recorded in 2023.
- Year-over-year, Price to Book surged 403.86% in 2023 and plunged 733.14% in 2025.
- Over 5 years, Price to Book stood at 171.61 in 2022, then decreased by 25.0% to 128.7 in 2023, then slipped by 17.01% to 106.81 in 2024, then tumbled by 69.69% to 32.38 in 2025, then sank by 90.97% to 2.92 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 2.92 in Q2 2026, 9.54 in Q1 2026, and 32.38 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.92 |
| Mar 31, 2026 | 9.54 |
| Dec 31, 2025 | 32.38 |
| Sep 30, 2025 | -65.62 |
| Jun 30, 2025 | -495.83 |
| Mar 31, 2025 | 323.86 |
| Dec 31, 2024 | 106.81 |
| Sep 30, 2024 | 191.56 |
| Jun 30, 2024 | 78.31 |
| Mar 31, 2024 | 168.50 |
| Dec 31, 2023 | 128.70 |
| Sep 30, 2023 | 106.78 |
| Jun 30, 2023 | 105.88 |
| Mar 31, 2023 | 74.07 |
| Dec 31, 2022 | 171.61 |
| Sep 30, 2022 | -842.81 |
| Jun 30, 2022 | -34.84 |
| Mar 31, 2022 | -956.10 |
| Dec 31, 2021 | 235.82 |
| Sep 30, 2021 | 140.03 |